GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Price-to-Owner-Earnings
Switch to:

China National Accord Medicines (SZSE:000028) Price-to-Owner-Earnings

: 17.99 (As of Today)
View and export this data going back to 1993. Start your Free Trial

As of today (2023-03-24), China National Accord Medicines's share price is ¥44.79. China National Accord Medicines's Owner Earnings per Share (TTM) ended in Sep. 2022 was ¥2.49. It's Price-to-Owner-Earnings for today is 17.99.


The historical rank and industry rank for China National Accord Medicines's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:000028' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.34   Med: 26.47   Max: 65.37
Current: 18

During the past 13 years, the highest Price-to-Owner-Earnings of China National Accord Medicines was 65.37. The lowest was 11.34. And the median was 26.47.


SZSE:000028's Price-to-Owner-Earnings is ranked worse than
62.16% of 37 companies
in the Medical Distribution industry
Industry Median: 16.32 vs SZSE:000028: 18.00

As of today (2023-03-24), China National Accord Medicines's share price is ¥44.79. China National Accord Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was ¥3.06. Therefore, China National Accord Medicines's PE Ratio for today is 14.64.

As of today (2023-03-24), China National Accord Medicines's share price is ¥44.79. China National Accord Medicines's EPS without NRI for the trailing twelve months (TTM) ended in was ¥3.06. Therefore, China National Accord Medicines's PE Ratio without NRI for today is 14.64.

During the past 13 years, China National Accord Medicines's highest PE Ratio without NRI was 48.18. The lowest was 9.49. And the median was 19.36.


China National Accord Medicines Price-to-Owner-Earnings Historical Data

The historical data trend for China National Accord Medicines's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.25 18.48 18.85 16.83 14.37

China National Accord Medicines Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.94 14.37 14.19 12.53 11.99

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

China National Accord Medicines Price-to-Owner-Earnings Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Price-to-Owner-Earnings falls in comparison to its industry or sector. The grey bar indicates the Price-to-Owner-Earnings's extreme value range as defined by GuruFocus.



China National Accord Medicines Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

China National Accord Medicines's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=44.79/2.49
=17.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines  (SZSE:000028) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


China National Accord Medicines Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines